The review says diffusion models do well at structure-based small-molecule design but struggle to ensure the molecules they generate can be synthesised.

The paper

The paper's details are OpenAlex's; the citation count is OpenAlex's, 18 Oct 2026. The line on the paper is machine-written, as noted under Why it matters.

Why it matters

Written by Claude (claude-sonnet-5-5) on 19 Oct 2026 from the paper's abstract (as arXiv publishes it) and its OpenAlex record. Machine-written context to help a reader: it is not evidence, it moves no number, and it may be wrong. The quoted sentence is the claim; where it stands is computed from the record. If it misreads the paper, tell the stewards.

The story so far

1. 1

   What the authors did

   The authors wrote a systematic review comparing how diffusion models are applied to designing small molecules and therapeutic peptides, looking at their representations, chemical spaces and design goals.

   Machine-written from the paper's abstract, as noted under Why it matters.

2. 2

   What they found

   • Diffusion models use one iterative denoising framework, adapted to the different molecular representations and design goals of small molecules and peptides.
   • For peptides, the main challenges are stability against proteolysis, proper folding and minimising immunogenicity.
   • Both domains share hurdles: scarce high-quality data, inaccurate scoring functions for validation, and the need for experimental validation.

   Machine-written from the paper's abstract, as noted under Why it matters.

3. 3

   What has been checked on Ecdysis

   Exuvia registered the claim on 18 October 2026, with a test written from the paper. No check has been filed yet.

What would check it

How far it has been checked

1. 1
   The object itself, checked againverification · not yet

   Not yet: re-run the paper's analysis on its own data, where the authors have published it.

2. 2
   New instances of the constructionreproduction · not yet

   Not yet: the same construction run afresh.

3. 3
   The designrobustness tests and arguments · not yet

   Nothing yet: change the method or the data and see whether it holds (a robustness test), or argue that the method does not test what the claim says.

How sure is the record?

Share this finding

Ready-made posts, written from the record. You post them yourself, from your own account; nothing is ever posted for anyone.

Click a post's text to select all of it. Both posts give the claim's standing on the record, and the longer one says what the checks show and what they do not; the wording changes when the record does. The longer post quotes the paper first, then gives the machine-written headline, marked as such; edit it as you like. To cite the claim, see Cite this claim.

What would prove it wrong

Refuted if an independent replication of a widely used structure‑based drug‑design benchmark demonstrates that diffusion models generate pocket‑fitting ligands with the desired physicochemical properties at least as often as a baseline method AND a systematic synthesis feasibility assessment shows that more than 70% of the generated molecules are synthesizable without additional constraints.

The test as Exuvia registered it on 18 Oct 2026, written from the paper's words.

The wider literature

Other claims from the same paper

• uncheckedFor therapeutic peptides, diffusion models focus on functional sequences and de novo structures, with stability, folding and immunogenicity as the main challenges.“Conversely, for therapeutic peptides, the focus shifts to generating functional sequences and designing de novo structures, where the primary challenges are achieving biological stability against pro…”
• uncheckedThe review says diffusion models for small molecules and for peptides share three hurdles: scarce good data, inaccurate scoring functions, and a need for lab validation.“Despite these distinct challenges, both domains face shared hurdles: the scarcity of high-quality experimental data, the reliance on inaccurate scoring functions for validation, and the crucial need…”

Headlines are machine-written from the paper's abstract, or from the quote and the paper's title where no abstract is open; each claim's own words are quoted beneath its headline.